R. Herbrecht

发表

Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment.

G. Salles, B. Coiffier, O. Casasnovas, 2001, The hematology journal : the official journal of the European Haematology Association.

The design of clinical trials that evaluate antifungal prophylaxis and combination therapy: introduction and overview.

R. Wenzel, J. Sobel, J. Wingard, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antifungal combination treatment: a future perspective.

L. Fornecker, R. Herbrecht, C. Fohrer, 2006, International journal of antimicrobial agents.

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases.

T. Calandra, M. Bassetti, C. Viscoli, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Caspofungin: the first representative of a new antifungal class.

Raoul Herbrecht, R. Herbrecht, V. Letscher-Bru, 2003, The Journal of antimicrobial chemotherapy.

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Patricia Muñoz, Angela Restrepo, Raoul Herbrecht, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High Incidence but Low Burden of Coronaviruses and Preferential Associations between Respiratory Viruses

S. Fafi-Kremer, R. Herbrecht, R. Kessler, 2013, Journal of Clinical Microbiology.

Pregnancy outcome in women with transfused beta-thalassemia in France

F. Galactéros, A. Hot, R. Herbrecht, 2021, Annals of Hematology.

Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.

J. Graybill, D. Kontoyiannis, R. Herbrecht, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease

R. Ebrahimi, J. Donnelly, R. Herbrecht, 2011, Mycoses.

Ventricular bigeminy associated with voriconazole, methadone and esomeprazole

V. Kemmel, R. Herbrecht, D. Levêque, 2011, International Journal of Clinical Pharmacy.

Antifungal Therapy: New and Evolving Therapies

R. Herbrecht, Y. Nivoix, Marie-Pierre Ledoux, 2020, Seminars in Respiratory and Critical Care Medicine.

The Enzymatic Basis of Drug-Drug Interactions with Systemic Triazole Antifungals

G. Ubeaud‐Séquier, L. Beretz, R. Herbrecht, 2008, Clinical pharmacokinetics.

Interactions of cyclosporine with antimicrobial agents.

J. Bergerat, R. Herbrecht, K. L. Liu, 1990, Reviews of infectious diseases.

Fatal Aspergillus fumigatus Myositis in an Immunocompetent Patient

J. Sibilia, R. Herbrecht, R. Javier, 2001, European Journal of Clinical Microbiology & Infectious Diseases.

Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization

Miguel Ángel Martínez, L. Miguet, A. van Dorsselaer, 2006, Proteomics.

An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group.

R Sylvester, L Collette, L. Collette, 1998, The Journal of infection.

Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients

A. Thiébaut, U. Flückiger, C. Cordonnier, 2007 .

Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers.

C. Cordonnier, R. Herbrecht, N. Milpied, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.

E. Thiel, D. Denning, H. Lode, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Achievements and goals of the EORTC Invasive Fungal Infections Group. European Organisation for Research and Treatment of Cancer.

F. Meunier, B. D. de Pauw, R. Herbrecht, 2002, European journal of cancer.

Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the Intergroupe Français du Myélome.

D. Denning, P. Moreau, O. Lortholary, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses.

B. Oppenheim, R. Herbrecht, S. Kusne, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

C. R. Pinkerton, D. Catovsky, F. Jacobs, 1997, British journal of haematology.

Combination of recombinant interferon alpha‐2A and vinblastine in advanced renal cell cancer

D. Jacqmin, J. Bergerat, F. Oberling, 1988, Cancer.

Risk stratification for invasive aspergillosis in immunocompromised patients

R. Herbrecht, V. Letscher-Bru, P. Bories, 2012, Annals of the New York Academy of Sciences.

Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients.

L. Pagano, G. Dimopoulos, M. Akova, 2011, The Journal of antimicrobial chemotherapy.

Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma.

B. Coiffier, H. Tilly, C. Gisselbrecht, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Cerebral aspergillosis in the era of new antifungals: the CEREALS national cohort study Nationwide CEREbral Aspergillosis Lesional study (CEREALS).

F. Cotton, F. Bonneville, M. Bougnoux, 2021, The Journal of infection.

Voriconazole: therapeutic review of a new azole antifungal

R. Herbrecht, 2004, Expert review of anti-infective therapy.

Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpura.

O. Garraud, L. Corash, P. Coppo, 2019, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia.

T. Franquet, H. Einsele, L. Pagano, 2022, The Lancet. Infectious diseases.

Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL).

M. Ziepert, N. Schmitz, C. Flowers, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I/II study of pixantrone in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkin lymphoma

J. Singer, P. Borchmann, R. Herbrecht, 2011, Leukemia & lymphoma.

Haemorrhagic and thrombotic diatheses in mouse models with thrombocytosis

C. Denis, R. Skoda, M. Freund, 2014, Thrombosis and Haemostasis.

Polycythemia vera transforming to acute myeloid leukemia and complex abnormalities including 9p homogeneously staining region with amplification of MLLT3, JMJD2C, JAK2, and SMARCA2.

R. Herbrecht, C. Gervais, S. Struski, 2008, Cancer genetics and cytogenetics.

Pharmacokinetic drug-drug interactions with methotrexate

R. Herbrecht, D. Levêque, B. Gourieux, 2011 .

Antifungal Stewardship in Hematology: Reflection of a Multidisciplinary Group of Experts.

J. Timsit, I. Yakoub-Agha, J. Mira, 2020, Clinical lymphoma, myeloma & leukemia.

Incidental Discovery of a COVID-19 Infection on a Reevaluation FDG PET/CT in a Patient Treated for Hodgkin Lymphoma

R. Herbrecht, C. Bund, Blandine Guffroy, 2020, Clinical nuclear medicine.

Magnetic Resonance Imaging of Cerebral Aspergillosis: Imaging and Pathological Correlations

J. Dietemann, D. Galanaud, S. Grand, 2016, PloS one.

Combination Antifungal Therapy for Invasive Aspergillosis

J. Wingard, F. Queiroz-Telles, D. Kontoyiannis, 2015, Annals of Internal Medicine.

18F-FDG PET/CT for the Diagnosis of Malignant and Infectious Complications After Solid Organ Transplantation

I. Namer, F. Hubelé, A. Imperiale, 2017, Nuclear Medicine and Molecular Imaging.

[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography for early evaluation of treatment efficacy in advanced non-Hodgkin lymphoma of uterine corpus: a case report.

A. Constantinesco, A. Imperiale, R. Herbrecht, 2007, Clinical lymphoma & myeloma.

10 Years Follow-up of the GELA LNH98.5 Study, First Randomized Study Comparing R-CHOP to CHOP Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma.

G. Salles, B. Coiffier, R. Bouabdallah, 2009 .

Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID‐19 and acute promyelocytic leukaemia

F. Schneider, R. Herbrecht, R. Beaujeux, 2020, British journal of haematology.

Prognostic factors in ovarian carcinoma in complete histologic remission at second-look surgery.

M. Hummel, B. Duclos, J. Bergerat, 1999, International Journal of Gynecological Cancer.

Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study.

G. Salles, A. Fischer, É. Oksenhendler, 2006, Blood.

Comparison of pixantrone-based regimen (CPOP-R) with doxorubicin-based therapy (CHOP-R) for treatment of diffuse large B-cell lymphoma.

J. Singer, R. Herbrecht, A. Engert, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Computer tomography in pulmonary invasive aspergillosis in hematological patients with neutropenia: an useful tool for diagnosis and assessment of outcome in clinical trials.

S. de Botton, A. Thiébaut, V. Latrabe, 2010, European journal of radiology.

Real‐world non‐interventional long‐term post‐authorisation safety study of ruxolitinib in myelofibrosis

R. Greil, A. Reiter, H. Gisslinger, 2020, British journal of haematology.

Review Article Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia

P. Kastner, M. Gaub, R. Herbrecht, 2013 .

Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia.

P. Kastner, M. Gaub, R. Herbrecht, 2013, American journal of blood research.

A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999.

O. Lortholary, P. Tilleul, R. Herbrecht, 2004, The Journal of antimicrobial chemotherapy.

Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs.

G. Salles, F. Berger, B. Coiffier, 1991, The American journal of medicine.

ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients

H. Einsele, L. Pagano, M. Aljurf, 2017, The Journal of antimicrobial chemotherapy.

Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis

M. Netea, S. Teerenstra, B. Kullberg, 2012, Journal of Clinical Microbiology.

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients.

J. Bergerat, P. Dufour, Kun Liu, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis

M. Netea, A. Earnest, S. Teerenstra, 2014, PloS one.

Using routine blood parameters to anticipate clinical outcomes in invasive aspergillosis.

M. Netea, A. Cook, B. Kullberg, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

T. Calandra, M. Bassetti, C. Viscoli, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Results of initial doxorubicin, 5‐fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast

D. Jaeck, B. Duclos, J. Bergerat, 1990, Cancer.

Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF).

F. Grenouillet, L. Millon, F. Morio, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.

J. Perfect, J. Wingard, T. Walsh, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.

M. Bassetti, C. Viscoli, B. Kullberg, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

J. Baddley, G. Rahav, V. Morrison, 2016, The Lancet.

Characterization of efficacy and safety of pathogen inactivated and quarantine plasma in routine use for treatment of acquired immune thrombotic thrombocytopenic purpura

J. Cazenave, A. Bohbot, L. Corash, 2018, Vox sanguinis.

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS.

T. Calandra, M. Bassetti, C. Viscoli, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Neutrophils differentially attenuate immune response to Aspergillus infection through complement receptor 3 and induction of myeloperoxidase

M. Netea, B. Kullberg, W. Chng, 2018, Cellular microbiology.

European expert opinion on the management of invasive candidiasis in adults.

J. Vincent, J. Meis, T. Calandra, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections.

L. Beretz, A. Zamfir, P. Lutun, 2006, The Journal of infection.

Early proinflammatory cytokines and C‐reactive protein trends as predictors of outcome in invasive Aspergillosis.

M. Netea, A. Earnest, S. Teerenstra, 2010, The Journal of infectious diseases.

EFFICACY AND SAFETY OF RITUXIMAB IN B-CELL POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: RESULTS OF A PROSPECTIVE MULTICENTRE PHASE II STUDY Running head: Rituximab in PTLD

G. Salles, A. Fischer, É. Oksenhendler, 2017 .

phase 2 study lymphoproliferative disorders: results of a prospective multicenter Efficacy and safety of rituximab in B-cell post-transplantation

G. Salles, A. Fischer, É. Oksenhendler, 2011 .

CHOP-R (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab) Compared to CPOP-R (Cyclophosphamide, Pixantrone, Vincristine, Prednisone, Rituxamib) in First-Line Therapy of Diffuse Large B Cell Lymphoma (DLBCL): An Interim Analysis.

R. Herbrecht, F. Weissinger, R. Jagt, 2007 .

A phase I study of pixantrone (BBR 2778) in combination with cyclophosphamide, vincristine and prednisone in patients with relapsed aggressive non-Hodgkin's lymphoma.

P. Borchmann, J. Harousseau, R. Herbrecht, 2003 .

Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study

M. Shivaprakash, M. Paesmans, L. Ameye, 2010, Bone Marrow Transplantation.

An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients.

M. Shivaprakash, M. Paesmans, L. Ameye, 2009, The Journal of antimicrobial chemotherapy.

A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis.

R. Betts, J. Baddley, G. Ruiz-Palacios, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies

S. de Botton, A. Thiébaut, R. Herbrecht, 2007, Cancer.

Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.

C. Gisselbrecht, É. Lepage, J. Lotz, 1996, Bone marrow transplantation.

Improvement in the outcome of invasive fusariosis in the last decade.

E. Anaissie, L. Pagano, M. Nucci, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Clinical characteristics and outcomes of invasive Lomentospora prolificans infections: Analysis of patients in the FungiScope® registry

M. Christner, L. Pagano, D. Seidel, 2020, Mycoses.

Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).

A. Barać, J. García-Martínez, D. Seidel, 2019, The Journal of antimicrobial chemotherapy.

Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008).

R. Porcher, M. Mohty, G. Socié, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

FungiScope™—Global Emerging Fungal Infection Registry

D. Seidel, A. Chowdhary, H. Wisplinghoff, 2017, Mycoses.

Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study.

B. Coiffier, O. Casasnovas, H. Tilly, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Systemic antifungal strategies in allogeneic hematopoietic stem cell recipients hospitalized in french hematology units: a post-hoc analysis of the cross-sectional observational AFHEM study

I. Yakoub-Agha, R. Herbrecht, J. Gangneux, 2022, BMC Infectious Diseases.

Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups.

J. Powers, J. Galgiani, C. Viscoli, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections

H. V. D. Lelie, H. Hoogsteden, W. Hop, 1998, British journal of haematology.

Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study

I. Yakoub-Agha, R. Herbrecht, J. Gangneux, 2018, Infectious Diseases and Therapy.

Assessment of high-priced systemic antifungal prescriptions.

P. Bachellier, P. Lutun, R. Herbrecht, 2017, Médecine et maladies infectieuses.

Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials

B. Kullberg, R. Herbrecht, J. Garbino, 2017, The Journal of antimicrobial chemotherapy.

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.

T. Calandra, M. Bassetti, C. Viscoli, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

ESCMID Diagnostic and management guideline for Candida diseases 2012: Developing European guidelines in clinical microbiology and infectious diseases.

T. Calandra, M. Bassetti, C. Viscoli, 2012 .

Mycograb for the treatment of invasive candidiasis.

R. Herbrecht, C. Fohrer, Y. Nivoix, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1998, Cancer.

The lipid formulations of amphotericin B

R. Herbrecht, V. Letscher-Bru, Y. Nivoix, 2003, Expert opinion on pharmacotherapy.

Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability

R. Herbrecht, V. Letscher-Bru, M. Tiphine, 1999, Transplant infectious disease : an official journal of the Transplantation Society.

The changing epidemiology of fungal infections: are the lipid‐based forms of amphotericin B an advance?

R. Herbrecht, 1996, European journal of haematology. Supplementum.

Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients.

T. Harrison, P. White, R. Herbrecht, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Emergence of unusual cytogenetic abnormalities under interferon-alpha therapy in patients with chronic myelogenous leukemia.

P. Dufour, R. Herbrecht, F. Maloisel, 1999, Cancer genetics and cytogenetics.

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

A. Barać, L. Pagano, B. Drénou, 2021, Journal of Hematology & Oncology.

Idiopathic Thrombocytopenic Purpura and Radiotherapy: A Case Report and Review of the Literature

R. Herbrecht, G. Noël, D. Antoni, 2020 .

Value of autologous bone marrow transplantation (ABMT) in 42 patients with follicular lymphomas responsive to conventional chemotherapy: a "France Autogreffe" study.

B. Coiffier, H. Tilly, P. Biron, 1996, Cancer detection and prevention.

Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients.

B. Coiffier, H. Tilly, J. Abgrall, 1994, Bone marrow transplantation.

Poly(ADP‐ribose)polymerase inhibitors‐associated myeloid neoplasms: a retrospective study from the French Network of Pharmacovigilance centres

R. Herbrecht, J. Alexandre, M. Lepelley, 2021, British journal of haematology.

Breakthrough invasive mould infections in patients treated with caspofungin.

R. Herbrecht, V. Letscher-Bru, A. Datry, 2012, Journal of Infection.

Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

D. Denning, J. Wingard, V. Morrison, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Forty-one recent cases of invasive zygomycosis from a global clinical registry.

A. Simon, Y. Roth, V. Rickerts, 2009, The Journal of antimicrobial chemotherapy.

Posaconazole as Salvage Therapy for Zygomycosis

M. Schuster, R. Kryscio, J. Wingard, 2006, Antimicrobial Agents and Chemotherapy.

Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects.

M. Kouba, J. Sinko, R. Herbrecht, 2013, The Journal of antimicrobial chemotherapy.

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.

J. Perfect, G. Rahav, F. Marty, 2016, The Lancet. Infectious diseases.

Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen.

J. Bergerat, F. Oberling, P. Dufour, 1992, Seminars in oncology.

Etoposide, ifosfamide and methotrexate combination chemotherapy in patients with aggressive non‐hodgkin's lymphoma after failure of the LNH 84 regimen

J. Bergerat, F. Oberling, P. Dufour, 2006, Hematological Oncology.

BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo

L. Miguet, L. Fornecker, S. Fournel, 2019, Scientific Reports.

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT).

T. Calandra, M. Bassetti, C. Viscoli, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

International Retrospective Analysis of 73 Cases of Invasive Fusariosis Treated with Voriconazole

F. Grenouillet, P. Biswas, O. Lortholary, 2010, Antimicrobial Agents and Chemotherapy.

Tuberculosis and atypical mycobacterial infections in ruxolitinib-treated patients with primary or secondary myelofibrosis or polycythemia vera.

L. Fornecker, R. Herbrecht, F. Maloisel, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Evaluation of Mass Spectrometry-Based Detection of Panfungal Serum Disaccharide for Diagnosis of Invasive Fungal Infections: Results from a Collaborative Study Involving Six European Clinical Centers

C. Viscoli, M. Titécat, P. Bochud, 2019, Journal of Clinical Microbiology.

Management of systemic fungal infections: alternatives to itraconazole.

R. Herbrecht, V. Letscher-Bru, Y. Nivoix, 2005, The Journal of antimicrobial chemotherapy.

Fungal Infections in Patients With Neutropenia

O. Lortholary, R. Herbrecht, V. Letscher-Bru, 2000, Drugs & Aging.

Changes in causes of death over time after treatment for invasive aspergillosis

J. Wingard, R. Herbrecht, P. Ribaud, 2008, Cancer.

Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.

R. Rubin, D. Denning, J. Wingard, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis.

J. Powers, J. Galgiani, C. Viscoli, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients.

J. Powers, J. Galgiani, C. Viscoli, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long‐term survival in post‐transplant lymphoproliferative disorders with a dose‐adjusted ACVBP regimen

J. Bergerat, P. Lutun, R. Herbrecht, 2006, British journal of haematology.

VP-16, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen

B. Duclos, J. Bergerat, F. Oberling, 2004, Cancer Chemotherapy and Pharmacology.

Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, É. Lepage, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis.

L. Miguet, L. Fornecker, A. van Dorsselaer, 2009, Journal of proteome research.

High dose melphalan and ABMT with or without abdominal radiotherapy as consolidation treatment for ovarian carcinoma in complete remission or with microscopic residual disease.

B. Duclos, J. Bergerat, A. Bohbot, 1991, European journal of gynaecological oncology.

Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs.

J. Armitage, J. Vose, B. Coiffier, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system

G. Rahav, F. Marty, R. Herbrecht, 2019, Medical mycology.

Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®

D. Pakstis, D. Seidel, J. Chander, 2019, Critical reviews in microbiology.

Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.

J. Sobel, G. Rahav, C. Viscoli, 2018, Clinical Infectious Diseases.

Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole

G. Rahav, R. Herbrecht, J. Maertens, 2018, Mycoses.

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

L. Pagano, T. Calandra, C. Viscoli, 2016, Haematologica.

Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis.

C. Elie, M. Wolff, O. Lortholary, 2015, Journal of Antimicrobial Chemotherapy.

Randomised, multicentre trial of micafungin vs. an institutional standard regimen for salvage treatment of invasive aspergillosis

C. Viscoli, R. Herbrecht, O. Cornely, 2015, Mycoses (Berlin).

Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries

L. Pagano, A. Simon, M. Vehreschild, 2013, Haematologica.

Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3)

L. Pagano, O. Lortholary, G. Petrikkos, 2013, Haematologica.

Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis

A. Glasmacher, A. Thiébaut, C. Cordonnier, 2006, Cancer.

Treatment of 21 Cases of Invasive Mucormycosis with Amphotericin B Colloidal Dispersion

E. Anaissie, G. Noskin, B. Oppenheim, 2001, European Journal of Clinical Microbiology and Infectious Diseases.

Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.

P. Moreau, A. Delmer, C. Cordonnier, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity.

M. Netea, B. Kullberg, B. Tai, 2013, The Journal of antimicrobial chemotherapy.

Cola beverage and delayed elimination of methotrexate.

R. Herbrecht, D. Levêque, R. Santucci, 2010, British journal of clinical pharmacology.

Delayed elimination of methotrexate associated with co-administration of proton pump inhibitors.

A. Lescoute, V. Kemmel, R. Herbrecht, 2010, Anticancer research.

Severe intoxication with methotrexate possibly associated with concomitant use of proton pump inhibitors.

A. Lescoute, J. Bergerat, V. Kemmel, 2010, Anticancer research.

A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm

R. Herbrecht, C. Gervais, E. Jeandidier, 2013, Leukemia.

Isavuconazole: A new broad-spectrum azole. Part 1: In vitro activity.

R. Herbrecht, Y. Nivoix, Marie-Pierre Ledoux, 2018, Journal de mycologie medicale.

Phase III study of patients with relapsed, refractory mantle cell lymphoma treated with temsirolimus compared with investigator's choice therapy

B. Coiffier, A. Strahs, G. Verhoef, 2008 .

Factors associated with coinfections in invasive aspergillosis: a retrospective cohort study.

P. Bachellier, R. Clere-Jehl, F. Schneider, 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

A. Thiébaut, U. Flückiger, C. Cordonnier, 2011, Bone Marrow Transplantation.

History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs

E. Andrès, J. Gottenberg, B. Goichot, 2017, Journal of clinical medicine.

Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia

Marc C. Jacob, M. Boubaya, J. Rossi, 2020, Leukemia.

Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised Patients.

E. Bow, C. Charbonneau, R. Herbrecht, 2015, Clinical therapeutics.

Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.

N. Mahlaoui, Y. Bertrand, A. Thiébaut, 2012, Journal of Antimicrobial Chemotherapy.

A retrospective series of gut aspergillosis in haematology patients.

A. Vekhoff, A. Thiébaut, O. Reman, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Invasive infections due to Candida norvegensis and Candida inconspicua: report of 12 cases and review of the literature.

A. Vekhoff, F. Grenouillet, P. Charles, 2013, Medical mycology.

Evaluation of Two Commercial Real-Time PCR Kits for Aspergillus DNA Detection in Bronchoalveolar Lavage Fluid in Patients with Invasive Pulmonary Aspergillosis

F. Forouzanfar, R. Herbrecht, R. Kessler, 2018, The Journal of Molecular Diagnostics.

Antifungal Therapy in Patients with Hematological Malignancies

R. Herbrecht, Y. Nivoix, 2011 .

Comparative survival and cost of antifungal therapy: posaconazole versus standard antifungals in the treatment of refractory invasive aspergillosis

R. Herbrecht, G. Papadopoulos, S. Rajagopalan, 2010, Current medical research and opinion.

Reply to Wolf et al.

R. Herbrecht, O. Cornely, J. Maetens, 2007 .

Invasive aspergillosis in the hematologic and immunologic patient: new findings and key questions in leukemia.

L. Fornecker, R. Herbrecht, V. Letscher-Bru, 2005, Medical mycology.

Liposomal Nystatin in Patients with Invasive Aspergillosis Refractory to or Intolerant of Amphotericin B

R. Sylvester, P. Moreau, G. Samonis, 2004, Antimicrobial Agents and Chemotherapy.

Posaconazole: a potent, extended‐spectrum triazole anti‐fungal for the treatment of serious fungal infections

R. Herbrecht, 2004, International journal of clinical practice.

Post-traumatic intracranial epidural Aspergillus fumigatus abscess.

G. Taglang, R. Herbrecht, J. Waller, 1997, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

Cell-surface expression of the TLR homolog CD180 in circulating cells from splenic and nodal marginal zone lymphomas

F. Berger, L. Miguet, L. Fornecker, 2013, Leukemia.

Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations

B. Drénou, P. Kastner, M. Gaub, 2013, Leukemia.

Paralytic ileus possibly associated with interaction between ritonavir/lopinavir and vincristine

J. Bergerat, R. Herbrecht, D. Levêque, 2009, Pharmacy World & Science.

Large deletions of the 5′ region of IKZF1 lead to haploinsufficiency in B‐cell precursor acute lymphoblastic leukaemia

H. Cavé, P. Kastner, L. Miguet, 2019, British journal of haematology.

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Raoul Herbrecht, Thomas J Walsh, Kieren A Marr, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

D. Denning, J. Wingard, V. Morrison, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Richard Sylvester, Raoul Herbrecht, John E Bennett, 2002, The New England journal of medicine.

Clinical pharmacokinetics of voriconazole.

R. Herbrecht, D. Levêque, Y. Nivoix, 2006, International journal of antimicrobial agents.

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.

J. Perfect, S. Holland, J. Sobel, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations.

S. Senn, C. Viscoli, J. Cooke, 2003, Clinical therapeutics.

Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases.

F. Lescure, O. Lortholary, I. Lutsar, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cunninghamella bertholletiae: an uncommon agent of opportunistic fungal infection. Case report and review.

J. Bergerat, F. Oberling, P. Dufour, 1991, Nouvelle revue francaise d'hematologie.

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections.

M. Ghannoum, R. Rubin, J. Solomkin, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Original Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system

G. Rahav, F. Marty, R. Herbrecht, 2020 .

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.

J. Perfect, C. White, R. Greene, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Successful Outcome of Treatment of a Disseminated Infection Due to Fusarium dimerum in a Leukemia Patient

R. Herbrecht, V. Letscher-Bru, E. Candolfi, 2002, Journal of Clinical Microbiology.

Simultaneous primary invasive cutaneous aspergillosis in two preterm twins: case report and review of the literature

R. Herbrecht, D. Astruc, V. Letscher-Bru, 2017, BMC Infectious Diseases.

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).

C. Heussel, R. Ebrahimi, A. Thiébaut, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Acremonium strictum Pulmonary Infection in a Leukemic Patient Successfully Treated with Posaconazole After Failure of Amphotericin B

R. Herbrecht, A. Zamfir, V. Letscher-Bru, 2002, European Journal of Clinical Microbiology and Infectious Diseases.

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.

Raoul Herbrecht, John E Bennett, R. Rubin, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient.

R. Herbrecht, V. Letscher-Bru, R. Kessler, 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Invasive Pulmonary Aspergillosis

R. Herbrecht, Y. Nivoix, Marie-Pierre Ledoux, 2004, Seminars in Respiratory and Critical Care Medicine.

Safety and Efficacy of Amphotericin B Colloidal Dispersion

A. Cavalier, R. Herbrecht, V. Letscher, 1999, Chemotherapy.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

C. Beigelman-Aubry, L. Pagano, C. Heussel, 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity.

R. Herbrecht, Y. Nivoix, Marie-Pierre Ledoux, 2018, Journal de mycologie medicale.

Safety and efficacy of Intralipid emulsions of amphotericin B J A ntimicrob Chemother 1997 ; 40 : 137 – 139

R. Herbrecht, V. Letscher, 2017 .

Successful treatment of visceral leishmaniasis with high-dose amphotericin B diluted in fat emulsion: a case report.

R. Herbrecht, C. Sosa, O. Villard, 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Safety of amphotericin B colloidal dispersion

R. Herbrecht, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.

R. Sylvester, B. Kullberg, J. Cohen, 2004, European journal of cancer.

Randomised comparison of voriconazole and amphotericin B in primary therapy of invasive aspergillosis.

D. Denning, R. Greene, J. Oestmann, 2002 .

Hospital Resource Utilization in Acute Invasive Aspergillosis (AIA) Patients (Pts) Treated with Voriconazole (VOR) or Amphotericin B (CAB).

J. Wingard, A. Marciniak, R. Herbrecht, 2004 .

Liposomal Amphotericin B (L-AMB) as Initial Therapy for Invasive Filamentous Fungal Infections (IFFI): A Randomized, Prospective Trial of a High Loading Regimen vs. Standard Dosing (AmBiLoad Trial).

R. Herbrecht, J. Maertens, O. Cornely, 2005 .

Efficacy of Amphotericin B Lipid Complex in the Treatment of Invasive Fungal Infections in Immunosuppressed Paediatric Patients

G. Leverger, R. Guillemain, R. Herbrecht, 2001, European Journal of Clinical Microbiology and Infectious Diseases.

Candida catenulata Fungemia in a Cancer Patient

R. Herbrecht, F. Maloisel, V. Letscher-Bru, 1999, Journal of Clinical Microbiology.

CASE REPORT Candida catenulata Fungemia in a Cancer Patient

R. Herbrecht, B. Lioure, M. Radosavljevic, 1999 .

New pharmacological opportunities for the treatment of invasive mould diseases.

R. Herbrecht, Marie-Pierre Ledoux, J. Denis, 2017, The Journal of antimicrobial chemotherapy.

Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature

D. Seidel, M. Hoenigl, R. Herbrecht, 2019, Mycoses.

Chronic disseminated Trichosporon asahii infection in a leukemic child.

R. Herbrecht, V. Letscher-Bru, P. Lutz, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Trichosporon infections: clinical manifestations and treatment

E. Guého, R. Herbrecht, K. L. Liu, 1993 .

[Trichosporon capitatum septicemia. Apropos of 5 cases].

P. Dufour, R. Herbrecht, F. Maloisel, 1992, Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression.

Disseminated Trichosporon capitatum infection in a patient with acute leukemia undergoing bone marrow transplantation.

J. Bergerat, F. Oberling, R. Herbrecht, 1990, Bone marrow transplantation.

[Trichosporon capitatum septicemia in immunosuppressed patients].

J. Bergerat, F. Oberling, P. Dufour, 1990, Pathologie-biologie.

Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration.

Raoul Herbrecht, R. Herbrecht, Y. Nivoix, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Invasive Scedosporium spp. and Lomentospora prolificans Infections in Pediatric Patients: Analysis of 55 Cases from FungiScope® and the Literature.

P. Soler-Palacín, D. Seidel, M. Cheng, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Candida albicans vertebral osteomyelitis treated successfully with fluconazole

J. Sibilia, R. Herbrecht, J. Kuntz, 1997 .

Adherence to recommendations for the use of antifungal agents in a tertiary care hospital.

L. Fornecker, G. Ubeaud‐Séquier, L. Beretz, 2012, The Journal of antimicrobial chemotherapy.

Systematic review and mixed treatment comparison of randomized evidence for empirical, pre-emptive and directed treatment strategies for invasive mould disease.

N. Freemantle, R. Herbrecht, P. Tharmanathan, 2011, The Journal of antimicrobial chemotherapy.

Isolated Renal Aspergillus Abscess in an AIDS Patient with a Normal CD4+ Cell Count on Highly Active Antiretroviral Therapy

C. Saussine, R. Herbrecht, V. Lindner, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Disseminated Trichosporon mycotoxinivorans, Aspergillus fumigatus, and Scedosporium apiospermum Coinfection after Lung and Liver Transplantation in a Cystic Fibrosis Patient

J. Pottecher, R. Herbrecht, V. Letscher-Bru, 2012, Journal of Clinical Microbiology.

Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B.

R. Ebrahimi, R. Herbrecht, J. Maertens, 2010, The Journal of antimicrobial chemotherapy.

Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019.

M. Christner, L. Pagano, D. Seidel, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Synergistic efficacy of recombinant human granulocyte colony-stimulating factor and amphotericin B against disseminated candidosis in non neutropenic mice

R. Herbrecht, P. Morier, J. Waller, 1996 .

Diagnosis of IPA in HIV: the role of the chest X-ray and radiologist

K. Rabe, D. Denning, H. Zonderland, 2004, European Radiology.

[Diffuse digestive tract B-cell lymphoma manifesting as exudative enteropathy].

B. Goichot, R. Herbrecht, M. Imler, 1998, Presse medicale.

Beta-D-glucan detection test: a step toward preemptive therapy for fungal infections in leukemic patients?

R. Herbrecht, A. Berceanu, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Lessons from a Case of Oromandibular Mucormycosis Treated with Surgery and a Combination of Amphotericin B Lipid Formulation plus Caspofungin

R. Herbrecht, M. Chenard, P. Schultz, 2010, Acta Haematologica.

Prospective study of bacteraemia in cancer patients. Results of a French multicentre study.

R. Herbrecht, M. Escande, 1998, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.

Prognostic Factors for Survival in Invasive Aspergillosis in Adult Oncohematological Patients.

J. Bergerat, P. Lutun, M. Velten, 2006 .

Epidemiological study of invasive pulmonary aspergillosis in a haematology unit by molecular typing of environmental and patient isolates of Aspergillus fumigatus.

R. Herbrecht, V. Letscher-Bru, E. Candolfi, 2005, The Journal of hospital infection.

Factors associated with overall and attributable mortality in invasive aspergillosis.

Philippe Lutun, Bruno Lioure, Karin Bilger, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Earlier diagnosis of angioinvasive pulmonary mold disease: is computed tomography pulmonary angiography a new step?

R. Herbrecht, M. Roedlich, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP‐EBMT, EORTC‐IDG and SEIFEM survey

A. Barać, L. Pagano, D. Seidel, 2020, Mycoses.

A European prospective invasive mould disease audit

Anne Sonet, Cornelia Lass-Flörl, Raoul Herbrecht, 2014 .

Cost effectiveness of posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for the French healthcare system

P. Moreau, R. Herbrecht, B. Dupont, 2011, Journal of medical economics.

18F-FDG PET/CT for invasive fungal infection in immunocompromised patients

A. Imperiale, G. Treglia, R. Herbrecht, 2018, QJM : monthly journal of the Association of Physicians.

Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy.

R. Leclercq, C. Cordonnier, A. Buzyn, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScope® - Global Registry for Emerging Fungal Infections.

D. Pakstis, H. Badali, D. Seidel, 2020, The Journal of infection.

Cerebral mucormycosis: neuroimaging findings and histopathological correlation

J. Pruvo, B. Lhermitte, J. Cottier, 2021, Journal of Neurology.

A multivariate analysis of the survival of patients with aggressive lymphoma

B. Coiffier, H. Tilly, C. Gisselbrecht, 1998 .

Alternance of chemotherapy does not improve results in aggressive non-Hodgkin's lymphoma: A prospective randomized study on 884 patients LNH87 protocol group 3: A gela study

P. Gaulard, B. Coiffier, H. Tilly, 1996 .

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.

T. Molina, B. Coiffier, H. Tilly, 2003, Blood.

Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.

V. Leblond, C. Cordonnier, R. Herbrecht, 1995, Journal of chemotherapy.

Methylprednisolone‐induced immune thrombocytopenia

M. Ducreux, P. Bierling, R. Herbrecht, 2020, American journal of hematology.

Pharmacokinetic drug–drug interactions with methotrexate in oncology

R. Herbrecht, D. Levêque, B. Gourieux, 2011, Expert review of clinical pharmacology.

13q deletions in B-cell lymphoproliferative disorders: frequent association with translocation.

A. Zamfir, R. Herbrecht, B. Audhuy, 2007, Cancer genetics and cytogenetics.

Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma.

B. Coiffier, A. Berkenblit, C. Gisselbrecht, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).

C Sebban, B. Coiffier, H. Tilly, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Piperacillin and netilmicin combination therapy for febrile episodes in neutropenic patients

B. Duclos, J. Bergerat, F. Oberling, 1990, Infection.

Fungal Infections Caused by Kazachstania spp., Strasbourg, France, 2007–2020

P. Bachellier, M. De Cian, R. Herbrecht, 2022, Emerging infectious diseases.

Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.

H. Tilly, A. Delannoy, C. Haioun, 1994, British Journal of Cancer.

Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

Pierre Morel, Raoul Herbrecht, Felix Reyes, 2002, The New England journal of medicine.

Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO).

S. Leprêtre, S. Kremer, L. Fornecker, 2015, Haematologica.

Towards novel paradigms for cancer therapy

H. Gronemeyer, M. M. Portal, V. Pavet, 2011, Oncogene.

standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma Intensive conventional chemotherapy (ACVBP regimen) compared with

T. Molina, B. Coiffier, H. Tilly, 2009 .

Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, P. Biron, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1997, Leukemia & lymphoma.

Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities

R. Herbrecht, B. Audhuy, C. Gervais, 2009, Leukemia.

Invasive Pulmonary Aspergillosis

R. Herbrecht, V. Letscher-Bru, M. Canuet, 2004, Seminars in respiratory and critical care medicine.

[Piperacilline/tazobactam combination+amikacin versus ceftazidime+amikacin in patients with neutropenia and fever. An open multicenter study. Groupe d'étude des Aplasies Fébriles].

A. Vekhoff, P. Cony-Makhoul, R. Herbrecht, 1995, Presse medicale.

Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA

G. Salles, O. Casasnovas, P. Feugier, 2011, Haematologica.

Longer‐term follow‐up and outcome by tumour cell proliferation rate (Ki‐67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL‐001(EMERGE) pivotal trial

J. Drach, T. Witzig, J. Rowe, 2015, British journal of haematology.

Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial

G. Juliusson, M. Montillo, T. Lissitchkov, 2012, British journal of haematology.

Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia.

L. Tremmel, G. Juliusson, M. Montillo, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia

N. Paul, L. Miguet, L. Fornecker, 2021, Leukemia.

A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia.

J. Gribben, M. Béné, F. Davi, 2011, Blood.

Paclitaxel-anthracycline combination chemotherapy in relapsing advanced ovarian cancer after platinum-based chemotherapy: a pilot study.

G. Deplanque, B. Duclos, J. Limacher, 1998, Gynecologic oncology.

Addition of Rituximab Improves Outcome of HIV Negative Patients with Burkitt Lymphoma Treated with the Lmba Protocol: Results of the Randomized Intergroup (GRAALL-Lysa) LMBA02 Protocol. (IGR sponsored LMBA02, NCT00180882)

G. Salles, B. Coiffier, O. Casasnovas, 2012 .

Rare oral metastasis from a probable large-cell neuroendocrine carcinoma of the lung

F. Hubelé, B. Goichot, F. Bornert, 2016 .

Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma

N. Paul, L. Fornecker, S. Cianférani, 2019, Scientific Reports.

Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials

M. Ziepert, N. Schmitz, C. Flowers, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Anti-pseudo-PCNA type 1 (anti-SG2NA) pattern: Track down Cancer, not SLE.

E. Andrès, V. Poindron, A. Korganow, 2016, Joint, bone, spine : revue du rhumatisme.

Invasive Pulmonary Aspergillosis

R. Herbrecht, Marie-Pierre Ledoux, 2023, Journal of fungi.

Efficacy and safety of Rituximab in B-cell post transplantation lymphoproliferative disorders (B-PTLD): Preliminary results of a multicenter, open label, phase II trial (M39037 TRIAL)

G. Salles, É. Oksenhendler, A. Moreau, 2002 .

Effect of pristinamycin on cyclosporin levels in bone marrow transplant recipients.

J. Bergerat, F. Oberling, R. Herbrecht, 1989, Bone Marrow Transplantation.

Micafungin prophylaxis in routine medical practice in adult and pediatric patients with hematological malignancy: a prospective, observational study in France.

R. Herbrecht, J. Dalle, S. Ducastelle-Leprêtre, 2019, Diagnostic microbiology and infectious disease.

Clinical antifungal efficacy trials in invasive aspergillosis: Consensus standards for trial design and room for improvement.

L. Fornecker, R. Herbrecht, Y. Nivoix, 2006, Medical mycology.

Severe Neutropenia and Agranulocytosis Related to Antithyroid Drugs: A Study of 30 Cases Managed in A Single Reference Center

E. Andrès, J. Gottenberg, B. Goichot, 2020, Medicines.

Idarubicin and high dose cytarabine: a new salvage treatment for refractory or relapsing non-Hodgkin's lymphoma.

J. Bergerat, P. Berthaud, P. Hurteloup, 1996, Leukemia & lymphoma.

Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS.

Alain Van Dorsselaer, Raoul Herbrecht, L. Miguet, 2006, Journal of proteome research.

Cytogenetic studies of a series of 43 consecutive secondary myelodysplastic syndromes/acute myeloid leukemias: conventional cytogenetics, FISH, and multiplex FISH.

R. Herbrecht, C. Gervais, S. Struski, 2006, Cancer genetics and cytogenetics.

Prospective study of bacteraemia in cancer patients

R. Herbrecht, French Study Group, M. Escande, 1998, Supportive Care in Cancer.

Drug-drug interactions of triazole antifungal agents in multimorbid patients and implications for patient care.

G. Ubeaud‐Séquier, R. Herbrecht, D. Levêque, 2009, Current drug metabolism.

Waldenström's macroglobulinemia harbors a unique proteome where Ku70 is severely underexpressed as compared with other B-lymphoproliferative disorders

M. Béné, H. Merle-Beral, V. Leblond, 2012, Blood Cancer Journal.

Risk factors for Gram-negative bacterial infections in febrile neutropenia.

R. Leclercq, C. Cordonnier, A. Buzyn, 2005, Haematologica.

Impact of clinical pharmacy services in a hematology/oncology inpatient setting.

R. Herbrecht, D. Levêque, B. Gourieux, 2015, Anticancer research.

A Phase I/II Study of Dose-Escalated Ifosfamide plus Carboplatin Combination for Advanced Ovarian Carcinoma

G. Deplanque, B. Duclos, J. Limacher, 1999, Oncology Research and Treatment.

Proceedings of Réanimation 2017, the French Intensive Care Society International Congress

K. Tarte, G. Le Roux, D. Boels, 2017, Annals of Intensive Care.

Updated Efficacy and Safety, and Exploratory Ki-67 Results For The MCL-001 Study Of Lenalidomide In Mantle Cell Lymphoma Patients Who Relapsed Or Were Refractory To Bortezomib

J. Drach, Michael E. Williams, T. Witzig, 2013 .

Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma.

P. Gaulard, C. Gisselbrecht, É. Lepage, 2001, The hematology journal : the official journal of the European Haematology Association.

Anticorps anti-pseudo-PCNA de type 1 (anti-SG2NA) : cherchez un cancer, pas le lupus ☆

E. Andrès, V. Poindron, A. Korganow, 2017 .

Rituximab vs Observation after High-Dose Consolidative First-Line Chemotherapy (HDC) with Autologous Stem Cell Transplantation in Poor Risk Diffuse Large B-Cell Lymphoma. Final Analysis of the LNH98-B3 GELA Study.

B. Coiffier, P. Feugier, H. Tilly, 2005 .

[Medication adverse events: Impact of pharmaceutical consultations during the hospitalization of patients].

M. Fischbach, R. Herbrecht, D. Levêque, 2014, Annales pharmaceutiques francaises.

Managing the challenges of invasive fungal infections.

R. Herbrecht, 2006, International journal of antimicrobial agents.

Bendamustine Versus Chlorambucil in Treatment-Naive Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL): Results of an International Phase III Study.

G. Juliusson, C. Dittrich, W. Knauf, 2007 .

Ruxolitinib Therapy in Myelofibrosis: Analysis of 241 Patients Treated in Compassionate Use (French “ATU” program) by the French Intergroup of Myeloproliferative Neoplasms (FIM).

P. Cony-Makhoul, B. Drénou, Anne Quinquenel, 2012 .

Bilberry extract (Antho 50) selectively induces redox-sensitive caspase 3-related apoptosis in chronic lymphocytic leukemia cells by targeting the Bcl-2/Bad pathway

J. Pincemail, M. Alhosin, V. Schini-Kerth, 2015, Scientific Reports.

Safety and tolerability of combination anidulafungin (ANID) and liposomal amphotericn B (LAmB) for the treatment of invasive aspergillosis (IA)

R. Herbrecht, J. Garbino, J. Maertens, 2004 .

Multimodality Diagnosis Approach of Cardiac Aspergillosis

A. Imperiale, P. Germain, R. Herbrecht, 2016, Echocardiography.

P397 Influence of underlying conditions on disease presentation and diagnostic strategy during pulmonary mucormycosis: Anational study of 114 cases

L. Millon, G. Guillerm, F. Morio, 2022, Medical Mycology.

Idiosyncratic drug-induced neutropenia and agranulocytosis

E. Andrès, J. Gottenberg, B. Goichot, 2017, QJM : monthly journal of the Association of Physicians.

Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (≥75 years): A Monocentric Cohort Study of 61 Cases

E. Andrès, J. Gottenberg, B. Goichot, 2016, Drugs - Real World Outcomes.

Idiosyncratic drug-induced neutropenia & agranulocytosis.

E. Andrès, J. Gottenberg, B. Goichot, 2017, QJM : monthly journal of the Association of Physicians.

[Standards, Options and Recommendations (SOR) for the surveillance and the prevention of cross infections in oncology. Fédération Nationale des Centres de Lutte Contre le Cancer].

P. Biron, C. Fuhrmann, R. Herbrecht, 2000, Bulletin du cancer.

HDAC inhibitors induce apoptosis in glucocorticoid-resistant acute lymphatic leukemia cells despite a switch from the extrinsic to the intrinsic death pathway.

H. Gronemeyer, M. Tsapis, P. Shankaranarayanan, 2007, The international journal of biochemistry & cell biology.

Reply to Denning

C. Heussel, R. Herbrecht, J. Maertens, 2007 .

Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis

J. Wingard, J. Mauskopf, A. Marciniak, 2007, Transplant infectious disease : an official journal of the Transplantation Society.

Alternating Chemotherapy Does Not Improve Results in Poor-prognosis Aggressive Lymphomas - Lnh87 Protocol Group-3 - a Gela Study

P. Gaulard, B. Coiffier, H. Tilly, 1993 .

Phase II Multicenter Study of Single-Agent Lenalidomide in Subjects with Mantle Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: The MCL-001 “EMERGE” Study

J. Drach, Michael E. Williams, T. Witzig, 2012 .

[Capillary hyperpermeability syndrome of the face].

E. Andrès, B. Goichot, J. Schlienger, 2000, Presse medicale.

Evaluation of serum Mucorales PCR for the diagnosis of Mucormycoses: The MODIMUCOR prospective trial.

L. Millon, F. Morio, F. Dalle, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

D. Denning, J. Wingard, V. Morrison, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Stimulation of B-Cell Lymphoproliferations with CpG-Oligonucleotide DSP30 Plus IL-2 Is More Effective than with TPA to Detect Clonal Abnormalities.

R. Herbrecht, B. Audhuy, C. Gervais, 2008 .

Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America

D. Denning, J. Wingard, V. Morrison, 2016 .

Systematic review and network meta-analysis of clinical outcomes associated with isavuconazole versus relevant comparators for patients with invasive aspergillosis

D. Kuessner, J. Posthumus, R. Herbrecht, 2018, Current Medical Research and Opinion.

Correspondence Mycograb for the Treatment of Invasive Candidiasis

R. Herbrecht, Y. Nivoix, 2006 .

Febrile pancytopenia as uncommon presentation of disseminated toxoplasmosis after BMT

R. Herbrecht, P. Bories, E. Candolfi, 2012, Bone Marrow Transplantation.

J. Perfect, J. Wingard, T. Calandra, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

D. Denning, J. Wingard, V. Morrison, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

European expert opinion on the management of invasive candidiasis in adults.

J. Vincent, J. Meis, T. Calandra, 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.

J. Perfect, S. Holland, J. Sobel, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL).

M. Ziepert, N. Schmitz, C. Flowers, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.

J. S. Daly, A. Casadevall, I. Sia, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Invasive Pulmonary Aspergillosis

R. Herbrecht, Marie-Pierre Ledoux, 2023, Journal of fungi.

Validation by real-life data of the new radiological criteria of the revised and updated consensus definition for invasive fungal diseases.

R. Herbrecht, A. Venkatasamy, Marie-Pierre Ledoux, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.

N. Mahlaoui, Y. Bertrand, A. Thiébaut, 2012, The Journal of antimicrobial chemotherapy.

Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis

M. Netea, S. Teerenstra, B. Kullberg, 2012, Journal of Clinical Microbiology.

Earlier diagnosis of angioinvasive pulmonary mold disease: is computed tomography pulmonary angiography a new step?

R. Herbrecht, M. Roedlich, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia.

L. Tremmel, G. Juliusson, M. Montillo, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial

G. Juliusson, M. Montillo, T. Lissitchkov, 2012, British journal of haematology.

Reply to Verweij et al

R. Rubin, D. Denning, J. Wingard, 2007 .

CPOP-R Versus CHOP-R as First-line Therapy for Diffuse Large B-cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-label, Multicenter Study

J. Singer, N. Dang, R. Herbrecht, 2011 .

Current Topic : Fungal Infections Vol . 16 , No . 1 Eur

R. Herbrecht, 2005 .

[Potential clinical impact of therapeutic education in patients treated with anticancer drugs].

A. Lescoute, J. Bergerat, L. Beretz, 2011, Bulletin du cancer.

Final results of the efficacy and safety of rasburicase (recombinant urate oxydase) for the prevention and treatment of hyperuricemia in patients with aggressive lymphoma (GRAAL 1 study).

B. Coiffier, O. Casasnovas, H. Tilly, 2002 .